Global Chronic Disease Management Market is valued at US$ 4.93 Billion in 2022 and it is expected to reach US$ 11.95 Billion by 2029 with a CAGR of 13.5% over the forecast period.
Global Chronic Disease Management Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2023-2029- Increasing prevalence of chronic diseases, rising number of geriatric population and growing technological advancements in chronic disease management are major factors anticipated to drive the growth of the Global Chronic Disease Management Market within the forecast period.
The management of symptoms of long-term disease is called as chronic disease management. The chronic diseases such as asthma, heart diseases cancer and others are controlled through chronic diseases management. Doctors can help to slow down the development of disease and help to control the symptoms by managing chronic disease. The management of chronic disease include study of health conditions, impact of one health condition on another health condition. The doctors manage to address patients’ unique needs and maintain their health and wellness to remain happy and productive through chronic disease management.
The Covid-19 pandemic has shown a significant impact on global chronic disease management market. The adoption of effective chronic disease management is increased during Covid-19 era, as first step for tackling chronic disease during pandemic is the development of a real-time clinical registry to identify and monitor high-risk and rising-risk patients. Thus, the development of synchronous and asynchronous virtual platforms for chronic disease management was increased during pandemic.
The global chronic disease management market is segmented into type, disease type, end-user and region & country level. On the basis of type, the global chronic disease management market is segmented into solution and services. On the basis of disease type, the market is segmented into cardiovascular diseases (CVD), cancer, arthritis, asthma, diabetes, chronic obstructive pulmonary disorders (COPD) and others. On the basis of end-users, the global chronic disease management market is segmented into ambulatory care centers, hospitals, diagnostic and imaging centers, home healthcare agencies, and others.
The regions covered in global chronic disease management market report are North America, Europe, Asia-Pacific, Latin America, and Rest of the World. Based on country level, the market of global chronic disease management market is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, Southeast Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.
Some of the key players for global chronic disease management -
One of the major factors driving the growth of the global chronic disease management market increasing prevalence of chronic diseases. The chronic diseases such as cancer, asthma, diabetes, blood pressure is increasing and the need for advanced chronic disease management is driving the market growth. For instance; the death rate of cardiovascular disease (CVD), based on 2018 data is 217.1 per 100,000 dies as per American Heart Association.
In addition, rising geriatric population is also supplementing the market growth. The geriatric population is more prone to cardiovascular diseases which will increase the demand for the chronic disease management for the forecast period. For instance; as per World Health Organization (WHO); the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
Moreover, growing technological advancements in this field are also boosting the market growth. For example; on April 13th, 2021, an advanced home health visit management solutions for patient cantered care launched by Wellsky for enhanced visit utilization management. Developments like this fuelling the market growth of the global chronic disease management market.
However, the high cost of chronic disease management may hamper the market growth. In spite of that, increasing adoption of advanced technologies may provide more opportunities for the further growth of global chronic disease management market.
The North America is expected to dominate the global chronic disease management market due to rising chronic diseases, presence of key players and availability of advanced healthcare infrastructure in this region. For instance; 6 in 10 adults in U.S have chronic diseases such as cancer and heart disease which are main cause of death and increasing number of these diseases will be main driver for the growth of the global chronic disease management market in the North America region.
In addition, the presence of key players such as Science Soft USA Corporation, Cognizant Trizetto Software Group, Inc., Allscripts, IBM Corporation is also driving the market growth. As well as IBM started working on AI to detect chronic diseases like Parkinson's, diabetes as per news published on May 28th, 2019. Moreover, availability of advanced healthcare infrastructure of North America is adding growth ro the global chronic disease management in this region.
Asia Pacific is the second largest region for the global chronic disease management market rising geriatric population, growing government initiatives, and increasing healthcare infrastructure. For instance; India’s ageing population will anticipated to increase from 60 million to 227 million by 2050 as per the World Health Organization.
In addition, growing government initiatives for implementation of IT programs in healthcare is also fostering the market growth in this region. Moreover, increasing healthcare infrastructure in developing countries like India and China is expected to boost the growth for the global chronic disease management market.
Easier Primary Care Access Improved Chronic Disease Management
On September 9th, 2022; According to new research published in Circulation Cardiovascular Quality and Outcomes, a peer-reviewed journal of the American Heart Association (AHA) study suggests primary care access can lead to improved chronic disease management for patients irrespective of socioeconomic and neighborhood factors they may face.
Payer Launches At-Home Chronic Disease Management, Education Solution
On June 1st, 2022; Blue Cross Blue Shield of Massachusetts implemented a Nudge unit to improve members’ options for at-home chronic disease management. Nudges are used in healthcare to alter strategies for presenting choices, leading consumers to the ability to make improved decisions. As one of the first health plans in the US to launch a Nudge Unit, Blue Cross intends to provide for various cases through the new platform.
|2016 - 2021
|2022 - 2029
|Market Size in 2022:
|USD 4.93 Billion
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2029:
|USD 11.95 Billion
|Tables, Charts & Figures:
|Allscripts Healthcare, LLC, Infosys Limited, Epic Systems Corporation, Hinduja Global Solutions Ltd., Cedar Gate Technologies, Cognizant, Pegasystems Inc., Casenet, LLC, Altruista Health, Koninklijke Philips N.V., ExlServings Holdings, Inc., NXGN Management, LLC, ZeOmega, Health Catalyst, Vivify Health, Inc., Medecision, and others
|By Type, By Disease Type, By End-Users
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®